The CP has provided clarity on some scoping issues, particularly in relation to MySuper products, investor directed portfolio services (IDPS) and customisable products.
MySuper products that offer an insurance component will not be subject to DDO and therefore issuers will not need to produce a target market determination (TMD) for either the MySuper product or the insurance element. However, Choice superannuation products are still covered by DDO and must meet the requirements, even if they are distributed alongside a MySuper product.
ASIC has also clarified that IDPS are considered to be products in their own right (separately from the underlying investments they offer) and that operators must comply with the DDO issuer obligations. Whilst this undoubtedly adds to the regulatory burden for IDPS operators, the platforms are relatively simple products and it should be possible to adopt a proportionate approach to meeting the requirements.
Where a financial product is customisable at the point of sale (e.g. selecting a waiting period for an income protection product), issuers are expected to consider the different options when determining the target market and may have to create separate TMDs for each permutation of the product. The same logic has also been applied to products that have different variations (e.g. differing terms, features, functionality or fees). Whilst ASIC acknowledges that the TMD is unlikely to change for every choice or option, this approach is likely to cause a shift in thinking for some organisations who may have been considering establishing high level TMDs that cover a number of similar products.